Most Doctors Say FDA Should Continue To Restrict Off-Label Drug Marketing: Study
A new survey finds that most doctors are against drug companies promoting medications for uses not approved by the FDA.…
«
»
A new survey finds that most doctors are against drug companies promoting medications for uses not approved by the FDA.…
Antidepressants are often prescribed off-label despite a lack of scientific evidence that they work well for uses not approved by the FDA, according to a new study.…
The FDA has issued a new draft guidance on how medical product manufacturers can add information that is not on the drug’s labels to promotions and advertising without misbranding their products.…
The makers of Abilify have agreed to pay $19.5 million to settle claims by 41 states and D.C. that it illegally marketed the antipsychotic for off-label uses.…
The FDA was urged by industry to relax restrictions on off-label drug marketing at a hearing this week, while critics warned that such a move would endanger patient health and safety.…
A consumer watchdog group is warning that proposed legislation to loosen off-label marketing restrictions for drugs could put patients at risk.…
A Public Citizen report warns of a steep decline in settlements and financial penalties leveled against drug companies by state and federal agencies in recent years.…
A Canadian study finds patients are more at risk of drug side effects when they are prescribed drugs for unapproved and untested uses.…
FDA blocked from enforcing off-label marketing laws against Amarin fish liver oil products.…